Learn about side effects, uses, and more of tamsulosin oral capsules. This is a generic drug that treats symptoms of benign prostatic hyperplasia (BPH).

Tamsulosin oral capsule is a prescription medication that’s used to treat the symptoms of benign prostatic hyperplasia (BPH). BPH is also called enlarged prostate. Tamsulosin oral capsule is ...

Tamsulosin has been used for the off-label treatment of lower urinary tract symptoms (LUTS) in women. Over the past few years, several randomized controlled trials (RCTs) have reported the ...

Tamsulosin is a generic prescription drug used to treat benign prostatic hyperplasia (BPH). Learn about the side effects it can cause and how to manage them.

HealthDay News — Tamsulosin does not significantly increase the urinary stone passage rate compared with placebo, according to a study published online June 18 in JAMA Internal Medicine. Andrew ...

Can the BPH drug tamsulosin prevent postoperative urinary retention in male patients undergoing surgery?

Tamsulosin was found to improve passage of larger, but not smaller, kidney stones compared to placebo, according to a study in the Annals of Emergency Medicine.

Tamsulosin works no better than placebo on small kidney stones, but does improve passage of more large kidney stones than placebo does, a new study concludes. 83.3 percent of patients treated with ...

Use of tamsulosin within 14 days of cataract surgery, but not of other alpha-blocker medications used to treat benign prostatic hyperplasia, was significantly associated with serious postoperative ...

I am an 84-year-old man in good health. I have been taking tamsulosin (Flomax) for the past six months for my enlarged prostate, and it works fine for problems with urination. However, it causes ...

Original Article Published: 23 September 2008 Efficacy and safety of dutasteride, tamsulosin and their combination in a subpopulation of the CombAT study: 2-year results in Asian men with moderate ...

(HealthDay)—Tamsulosin does not significantly increase the urinary stone passage rate compared with placebo, according to a study published online June 18 in JAMA Internal Medicine.